Recreational Stimulant Users

A Phase 1, Double-Blind, Single-Dose, 3-Treatment, 3-Period, 6-Sequence, Randomized, Crossover Study to Compare the Abuse Potential and Pharmacokinetics of KP415 API with d-Methylphenidate API Administered Intravenously in Healthy Nondependent Recreational Stimulant Users

Participants must meet the following criteria

  • Male or female volunteers 18-50 years of age

Study Visits

  •  1 in-house stay of 13 nights/14 days

  • 1 follow up visit

Compensation

  • Up to $4,345 for time and travel